Intended Use

PhiCal Test (Calprest) is a FDA approved quantitative enzyme-linked immunoassay (ELISA) for detection of increased concentrations of calprotectin in plasma, cerebrospinal fluid, synovial fluid, urine or stools as a consequence of disease in relevant organs.

 

During septicaemia, plasma calprotectin levels will rise more rapidly than C-reactive protein since increased synthesis of the latter by the liver takes time, while calprotectin is pre-formed in the leukocytes. (personal observations)

---

Next page: Stool Samples  Previous page: KIT CONTENT / INSTRUCTIONS